ASPEN:  10,119   +352 (+3.60%)  19/06/2019 00:00

South African drugmaker Aspen in talks with potential European partner

JOHANNESBURG, May 22 (Reuters) - South African drugmaker Aspen Pharmacare said on Wednesday it is in talks with a potential partner in Europe after announcing in March a strategic review of its European and domestic commercial pharmaceuticals businesses.

Without giving details, in March, Aspen said under the first phase of the review it would split its South African commercial pharmaceuticals business into two divisions to sharpen its focus.

On Wednesday it advised shareholders in a brief statement to exercise caution when dealing in the company's shares. (Reporting by Nqobile Dludla, editing by Louise Heavens)

2019-05-22 14:42:29

© 2019 Thomson Reuters. All rights reserved. Reuters content is the intellectual property of Thomson Reuters or its third party content providers. Any copying, republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters. Thomson Reuters shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. "Reuters" and the Reuters Logo are trademarks of Thomson Reuters and its affiliated companies.